|
Status |
Public on Sep 11, 2014 |
Title |
SF2077 (HG-U133A) |
Sample type |
RNA |
|
|
Source name |
GBM tumor
|
Organism |
Homo sapiens |
Characteristics |
site: Cerebrum:__Frontal_lobe gender: male age: 66.3 survival: 141.1 censored: no
|
Biomaterial provider |
UCSF
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was isolated using Trizol and purified with Qiagen RNeasy columns
|
Label |
biotin
|
Label protocol |
Approximately 1-5 ug of total RNA was processed to produce biotynylated cRNA targets
|
|
|
Hybridization protocol |
Standard Affymetrix procedure
|
Scan protocol |
Standard Affymetrix procedure
|
Data processing |
R/Bioconductor RMA processing with custom CDF v.18.0.0, ENTREZG
|
|
|
Submission date |
Sep 11, 2014 |
Last update date |
Sep 11, 2014 |
Contact name |
Joseph Costello |
Organization name |
UCSF
|
Department |
NeuroSurgery
|
Street address |
1450 3rd St
|
City |
San Francisco |
State/province |
CA |
ZIP/Postal code |
94158 |
Country |
USA |
|
|
Platform ID |
GPL19184 |
Series (1) |
GSE61335 |
AKT pathway genes define 5 prognostic subgroups in glioblastoma |
|